Webinars
April 16, 2024
Moderated by Jennifer Chu, Ph.D., FreeThink Technologies
Speaker: Sheri Shamblin, Ph.D., Aleurites Consulting
April 9, 2024
Moderated by Jennifer Chu, Ph.D., FreeThink Technologies
Speaker: Maria Krisch, Ph.D., FreeThink Technologies
April 2, 2024
Moderated by Jennifer Chu, Ph.D., FreeThink Technologies
Speaker: Kenneth C. Waterman, Ph.D., FreeThink Technologies
March 26, 2024
Moderated by Jennifer Chu, Ph.D., FreeThink Technologies
Speaker: Jessica Kelly, FreeThink Technologies
Nitrosamines Webinar Series: Understanding and Reducing Nitrosamine Formation in Solid Drug Products
November 14, 2023
Moderator: Kenneth C. Waterman. Ph.D., President- FreeThinkTechnologies, Inc,
Speaker: Garry Scrivens, PhD, Pfizer
Nitrosamines Webinar Series: The Chemistry of N-Nitrosamines: Insights and Implications
October 31, 2023
Moderator: Kenneth C. Waterman. Ph.D., President- FreeThinkTechnologies, Inc,
Speaker: Steven Baertschi, PhD, President, Baertschi Consulting
Nitrosamines Webinar Series: Use of an in silico tool to determine the molecular susceptibility of compounds forming nitrosamine degradation products
October 3, 2023
Moderator: Kenneth C. Waterman. Ph.D., President- FreeThinkTechnologies, Inc,
Speaker: Rachel Hemingway, PhD, Principal Scientist, Zeneth Project Lead
Nitrosamines Webinar Series: New Approaches to set AI for NDSRI
September 19, 2023
Moderator: Kenneth C. Waterman. Ph.D., President- FreeThinkTechnologies, Inc,
Speaker: Mariah Ultramari, PhD, Toxicologist and CEO of Spektra Consulting
Recorded Webinar Series in China: Pharmaceutical Stability Prediction Using ASAPprime®
March 12, 2023
Sessions 1, 2, 3
Moderator: Dr. Shaw, Executive Director for the Xieyi R&D institute, China.
Speaker: Kenneth C. Waterman. Ph.D., President- FreeThinkTechnologies, Inc, US, Dr. Gao Yang. Ph.D., BeiGene and Su Shengmin. Ph.D., Shanghai, Johnson & Johnson
The series features the application of ASAP technology in stability modeling.
FreeThink Technologies Webinar Series: Accelerated Stability Assessment Program (ASAP) for Oxygen Sensitivity
September 21, 2021
Moderator: Patrick Kelleher, Senior Scientist- FreeThinkTechnologies, Inc
Speaker: Kenneth C. Waterman. Ph.D., President- FreeThinkTechnologies, In
“Predicting Shelf Life with the Accelerated Stability Assessment Program (ASAP) and ASAPprime®”
October 21st, 2020
From the Stability Program Conference 2020, organized by International Pharmaceutical Academy (IPA).
Moderator: Dr. Pauline McGregor (IPA Conference Chair)
Speaker: Dr. Kristina Flavier
“Use of Modern Accelerated Stability Methods in Regulatory Filings”
October 7th, 2020
From the KENx Laboratory University 2020 Conference.
Speaker: Dr. Ken Waterman
“Shelf Life Modeling using ASAP (Accelerated Stability Assessment Program)”
October 5th, 2020
From the KENx Laboratory University 2020 Conference.
Speaker: Dr. Patrick Kelleher
“Rapid Development of Stable Tableted Drug Products”
September 16th, 2020
Moderator: Dr. Jennifer Chu
Speaker: Dr. Ken Waterman
“Extend the Shelf-Life of Oral Solid Doses with Activ-Blister Solutions”
August 26th, 2020
Speakers: Laura Zurlinden (PCI Pharma Services), Tommy Genetski (Aptar CSP Technologies) and Badre Hammond (Aptar CSP Technologies)
“Making Better Packaging Decisions, Faster”
July 28th, 2020
Moderator: Jon Moyer (3Bar Biologics)
Speaker: Dr. Ken Waterman
“Introduction to ASAP and Speeding Product Development”
June 23rd, 2020
Introduction: Rebecca Tan (International Pharmaceutical Academy)
Moderator: Dr. Maria Krisch
Speaker: Dr. Ken Waterman
“Selecting Primary Packaging for Stability for Solid Dosage Forms”
From the FreeThink Technologies Webinar Series
June 9th, 2020
Moderator: Dr. Alisa Waterman
Speaker: Dr. Ken Waterman
“cGMP ASAP”
From the FreeThink Technologies Webinar Series
May 19th, 2020
Moderator: Dr. Maria Krisch
Introduction: Dr. Ken Waterman
Speakers: Dr. Dorothy Kopchik and Tom Morison
“An Introduction to the ASAPprime® Software and Science”
February 4th, 2020
Speaker: Dr. Ken Waterman
“Rethinking Oral Solid Dose Packaging”
March 28th, 2019
Speakers: Badre Hammond (Aptar Pharma), Craig Voellmicke (Aptar CSP Technologies) and Dr. Maria Krisch
Part 1
“Maximizing the Accuracy of ASAP Predictions”
Speaker: Dr. Garry Scrivens (Pfizer Pharmaceuticals)
Part 2 (start time 32:30)
“ASAP Case Study – Nicorette® Lozenge”
Speaker: Dr. Lilan Chen (GSK Consumer Health)